No definition available.
Benign neoplasm of other and unspecified female genital organs
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_FEMALE_GEN_OTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
986 |
4. Check minimum number of eventsNone |
986 |
5. Include endpoints |
1601 |
6. Filter based on genotype QC (FinnGen only) |
1601 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna organorum genitalium femininorum aliorum et non specificatorum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of other and unspecified female genital organs
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11216 | 11216 | - |
| Only index persons | 10243 | 10243 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.32 | 0.32 | - |
| Only index persons | 0.38 | 0.38 | - |
| Median age at first event (years) | |||
| Whole population | - | 41.94 | - |
| Only index persons | - | 40.87 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1601 | 1601 | - |
| Unadjusted period prevalence (%) | 0.55 | 0.55 | - |
| Median age at first event (years) | 41.01 | 41.01 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1436
- Matched controls
- 14359
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
+∞
323.0
459
*
D28.1
ICD-10 Finland
Benign neoplasm: Vagina
3157.8
290.6
271
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
37.9
153.5
197
60
22120
ICD-8 Finland
Benign neoplasm of other female genital organs, Vulva
+∞
129.1
122
*
22101
ICD-8 Finland
Benign neoplasm of other female genital organs, Fallopian tube and broad ligament
+∞
107.7
102
*
22110
ICD-8 Finland
Benign neoplasm of other female genital organs, Vagina
+∞
97.0
92
*
D28.2
ICD-10 Finland
Benign neoplasm: Uterine tubes and ligaments
+∞
76.8
73
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
36.2
75.9
98
29
2210A
ICD-9 Finland
Benign neoplasm of other female genital organs, Fallopian tube and uterine ligaments
+∞
57.7
55
*
D28.9
ICD-10 Finland
Benign neoplasm: Female genital organ, unspecified
569.4
56.0
55
*
22121
ICD-8 Finland
NA
+∞
51.4
49
*
22122
ICD-8 Finland
NA
+∞
50.3
48
*
D28.7
ICD-10 Finland
Benign neoplasm: Other specified female genital organs
+∞
37.7
36
*
22199
ICD-8 Finland
Benign neoplasm of other female genital organs, Unspecified site
+∞
29.3
28
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.7
28.6
217
890
2211A
ICD-9 Finland
Benign neoplasm of other female genital organs, Vagina
+∞
28.2
27
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
10.5
25.1
49
48
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.2
24.2
95
238
22111
ICD-8 Finland
NA
+∞
16.7
16
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
12.7
196
1097
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
12.6
518
3843
N75.0
ICD-10 Finland
Cyst of Bartholin gland
6.2
12.6
33
54
8412
FHL
Vaginal tumor removal
37.9
12.2
15
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.9
12.1
201
1155
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
11.7
938
8008
LEB00
NOMESCO Finland
Biopsy of vagina
3.7
11.6
49
134
LEB20
NOMESCO Finland
Marsupialisation of vaginal cyst
21.6
10.7
15
7
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
10.7
495
3742
N90.7
ICD-10 Finland
Vulvar cyst
10.1
10.5
20
20
2218X
ICD-9 Finland
Benign neoplasm of other female genital organs, Other specified sites of female genital organs
+∞
9.4
9
*
UKC02
NOMESCO Finland
Cystoscopy
1.8
9.0
156
906
8206
FHL
Removal of the parovarial cyst
50.3
8.7
10
*
8473
FHL
Guinea pig or gland excision
9.0
8.5
17
19
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.4
870
7535
R01AD09
ATC
mometasone; nasal
1.4
8.2
636
5229
J02AC01
ATC
fluconazole; systemic
1.4
8.1
688
5749
62212
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Bartholinitis acuta
9.0
8.0
16
18
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.8
7.9
25
53
M25.5
ICD-10 Finland
Pain in joint
1.4
7.9
406
3096
D82
ICPC
Teeth/gum disease
1.4
7.6
456
3576
X01
ICPC
Genital pain female
5.8
7.5
20
35
M54.5
ICD-10 Finland
Low back pain
1.4
7.5
448
3503
ULA02
NOMESCO Finland
Kolposcopy
1.7
7.4
161
1006
N39.3
ICD-10 Finland
Stress incontinence
1.7
7.1
149
917
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.9
7.1
41
144
J01DB01
ATC
cefalexin; oral
1.4
7.1
1122
10283
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
7.0
312
2305
J01AA02
ATC
doxycycline; systemic
1.4
7.0
1106
10117
M01AE02
ATC
naproxen; oral, rectal
1.3
6.9
780
6747
N36.1
ICD-10 Finland
Urethral diverticulum
13.8
6.9
11
8
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.9
536
4374
2200A
ICD-9 Finland
Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]
3.4
6.7
30
89
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.6
412
3235
8204
FHL
Salpingo-oophorectomy
3.0
6.6
36
124
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.6
1228
11492
21899
ICD-8 Finland
Uterine fibroma
1.9
6.6
92
501
LCD00
NOMESCO Finland
Hysterectomy
1.8
6.4
98
549
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
6.4
282
2079
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.4
693
5929
A02BC02
ATC
pantoprazole; systemic
1.3
6.3
897
7981
S18
ICPC
Laceration/cut
1.3
6.3
534
4399
R03AC02
ATC
salbutamol; inhalant
1.3
6.3
727
6274
N89.9
ICD-10 Finland
Noninflammatory disorder of vagina, unspecified
7.1
6.2
14
20
E000001
ATC
NA
1.5
6.2
261
1906
LAC31
NOMESCO Finland
Laparoscopic excision of paraovarian cyst
12.6
6.1
10
8
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
5.2
6.0
17
33
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
6.0
523
4320
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
309
1767
1.93
21.67
5.0
4.5
34.2
33.9
%
0.20
231
1144
1177
10645
1.40
7.87
4.5
4.2
12.0
12.7
mm/h
1.42
1078
9832
607
4990
1.35
7.42
3.5
3.5
25.9
148.8
ng/l
0.69
367
3264
534
4339
1.35
6.94
2.4
2.4
58.3
58.9
u/l
0.05
489
3972
78
418
1.91
6.55
3.9
3.5
25.4
25.0
mmol/l
0.59
70
386
18
46
3.95
6.44
1.1
2.3
1.7
2.5
ug/l
0.66
13
24
984
8783
1.31
6.34
3.3
3.0
43.3
42.6
u/l
0.08
910
8110
107
641
1.72
6.25
3.5
3.3
1.9
1.9
mmol/l
0.01
83
490
83
468
1.82
5.97
2.1
2.0
10878.0
4664.6
u/l
0.43
37
201
110
675
1.68
5.90
3.6
3.4
5.2
5.2
kpa
0.02
104
623
1066
11578
0.76
5.87
17.0
16.4
13.7
13.7
%
0.07
1042
11306
748
6488
1.29
5.75
5.4
5.1
1.2
1.2
mmol/l
0.60
644
5855
1488
14259
1.62
5.73
15.6
15.0
139.8
139.7
mmol/l
0.68
1453
13877
1491
14298
1.62
5.68
15.7
15.2
3.9
3.9
mmol/l
0.24
1453
13889
1183
10908
1.32
5.60
7.2
7.2
76.1
77.6
u/l
0.63
1103
10218
825
7295
1.27
5.25
5.0
5.7
9.9
10.3
umol/l
0.53
775
6884
757
6637
1.27
5.12
3.8
3.9
—
—
—
0
0
45
220
2.08
4.95
1.4
1.4
28.6
31.0
u/l
0.17
35
186
1043
9534
1.27
4.83
5.5
4.9
4779.1
2747.9
e6/l
0.21
15
132
411
3370
1.30
4.69
2.2
2.1
—
—
—
0
0
322
2561
1.32
4.59
1.8
1.7
1223.8
1208.0
nmol/l
0.09
236
1880
37
173
2.17
4.58
1.4
1.3
—
—
—
0
0
37
174
2.15
4.52
1.5
1.3
—
—
—
0
0
37
175
2.14
4.46
1.5
1.3
—
—
—
0
0
15
45
3.36
4.33
1.5
1.2
—
—
—
0
0
15
45
3.36
4.33
1.5
1.2
—
—
—
0
0
37
179
2.09
4.23
1.5
1.3
—
—
—
0
0
37
181
2.07
4.12
1.5
1.3
—
—
—
0
0
76
476
1.63
3.85
1.9
1.8
—
—
—
0
0
36
180
2.02
3.80
1.5
1.3
—
—
—
0
0
1440
13869
1.38
3.69
14.2
13.4
19.0
21.0
mg/l
1.62
1164
10873
34
169
2.03
3.66
1.6
1.5
2.3
4.7
ug/l
0.90
26
146
337
2779
1.27
3.59
1.3
1.3
20.7
34.9
iu/ml
3.56
96
926
52
304
1.73
3.44
1.4
1.3
—
—
—
0
0
177
1345
1.36
3.43
2.0
2.0
379.5
372.2
nmol/l
0.19
152
1227
655
5834
1.21
3.35
2.0
2.0
102.6
97.7
pmol/l
1.33
310
2730
857
7834
1.20
3.30
4.1
4.1
6.6
6.6
mmol/l
0.08
796
7269
62
386
1.63
3.26
1.4
1.3
—
—
—
0
0
79
522
1.54
3.24
2.0
1.9
—
—
—
0
0
1368
13124
1.29
3.23
12.5
12.6
79.9
79.9
ml/min/173m2
0.01
1145
10751
787
7170
1.19
3.05
6.5
5.9
1.2
1.2
mmol/l
0.24
642
6039
1328
12719
1.26
3.01
6.0
5.6
39.5
39.4
mmol/mol
0.18
1216
11719
203
1607
1.30
2.98
17.9
22.5
1.3
1.3
inr
0.01
27
218
8
17
4.72
2.92
1.9
2.7
1.1
1.0
u/field
—
8
17
220
1766
1.28
2.90
6.8
6.5
—
—
—
0
0
7
14
5.02
2.73
1.1
1.4
—
—
—
0
0
1355
13044
1.25
2.70
4.3
3.9
1.2
1.3
mmol/l
0.17
1227
11866
1505
14703
1.39
2.58
11.0
10.5
23.6
23.4
u/l
0.10
1449
14159
20
94
2.14
2.55
1.1
1.1
14.3
13.1
iu/ml
—
5
24
15
62
2.43
2.54
1.5
1.2
—
—
—
0
0
57
375
1.54
2.45
1.1
1.1
—
—
—
0
0
1230
11763
1.20
2.40
5.0
4.6
14.7
14.8
pmol/l
0.39
1107
10739
9
27
3.35
2.39
3.6
2.0
—
—
—
0
0
9
27
3.35
2.39
2.9
1.3
100.5
74.8
ng/l
—
9
27
15
64
2.36
2.39
1.5
1.2
—
—
—
0
0
428
3764
1.19
2.37
2.6
2.9
926.9
1135.9
ng/l
0.63
352
3163
91
666
1.39
2.29
1.5
1.5
—
—
—
0
0
1409
13674
1.25
2.28
4.8
4.4
4.8
4.9
mmol/l
2.38
1294
12622
216
1784
1.24
2.27
2.2
2.1
107.8
116.6
ug/g
0.23
167
1383
7
18
3.90
2.25
1.3
1.1
—
—
—
0
0
1399
13570
1.25
2.25
4.8
4.4
1.6
1.6
mmol/l
0.35
1277
12453
1383
13399
1.24
2.24
6.0
5.5
3.5
2.1
mu/l
0.38
1276
12310
714
6566
1.16
2.23
2.4
2.3
81.1
79.7
nmol/l
0.64
612
5893
470
4188
1.17
2.21
2.1
2.1
134.1
176.0
u/l
1.11
435
3919
312
2690
1.20
2.15
1.3
1.3
6.9
12.4
u/ml
0.98
120
1048
381
3344
1.18
2.14
2.3
2.4
5177.2
5168.3
umol/l
0.00
322
2865
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
0
57
0.00
2.05
0.0
1.1
—
—
—
0
0
62
437
1.44
1.97
2.1
1.9
4.0
2.3
ug/l
0.37
49
387
418
3724
1.17
1.94
4.4
4.4
0.0
0.0
estimate
0.28
149
1287
37
234
1.59
1.94
1.8
1.4
0.4
0.3
nmol/l
0.44
29
177
33
515
0.63
1.86
1.8
2.3
10.3
10.0
g/l
0.14
24
440
22
122
1.81
1.84
1.8
1.4
—
—
—
0
0
386
3445
1.16
1.74
1.5
1.4
—
—
—
0
0
149
1219
1.25
1.74
2.1
3.6
26.3
61.3
u/ml
3.33
144
1180
14
68
2.07
1.70
2.9
1.8
947.2
752.3
e6/l
—
9
27
154
1272
1.23
1.66
2.0
2.0
—
—
—
0
0
11
49
2.25
1.63
1.1
1.1
—
—
—
0
0
1427
13948
1.21
1.63
5.2
5.0
2.8
2.8
mmol/l
1.72
1306
12808
452
4099
1.14
1.62
3.3
3.0
6.6
6.4
mmol/l
0.29
374
3435
155
1286
1.23
1.61
1.9
2.1
0.2
0.2
g/l
0.34
142
1218
79
605
1.32
1.57
1.4
1.6
—
—
—
0
0
353
3158
1.15
1.54
1.6
1.8
0.9
1.1
mg/l
0.64
264
2409
1390
13567
1.19
1.54
5.0
4.6
5.8
5.8
mmol/l
0.06
1266
12338
33
217
1.53
1.52
1.2
1.3
—
—
—
0
0
19
108
1.77
1.51
1.7
1.3
—
—
—
0
0
19
108
1.77
1.51
1.7
1.3
—
—
—
0
0
19
108
1.77
1.51
1.7
1.3
—
—
—
0
0
1546
15271
1.36
1.45
21.5
20.2
4.4
4.4
e12/l
0.29
1505
14837
137
1136
1.23
1.45
1.9
1.8
—
—
—
0
0
13
66
1.98
1.43
1.9
1.8
—
—
—
0
0
9
39
2.31
1.43
1.0
1.1
—
—
—
0
0
1545
15263
1.35
1.42
21.5
20.2
263.7
263.0
e9/l
0.18
1507
14877
39
552
0.70
1.42
2.1
2.3
3.7
3.7
g/l
0.06
24
395
77
598
1.30
1.41
1.2
1.3
0.2
1.1
u/ml
—
5
52
671
6282
1.12
1.40
3.0
2.8
87.2
95.5
ug/l
0.95
604
5803
28
181
1.56
1.40
2.1
2.1
28.1
25.9
mg/l
—
8
49
1546
15276
1.35
1.40
21.6
20.3
131.8
131.7
g/l
0.10
1526
15057
29
433
0.66
1.39
1.9
2.1
38.2
37.9
g/l
0.06
22
373
22
134
1.65
1.39
1.8
1.3
—
—
—
0
0
28
182
1.55
1.37
1.7
1.4
277.1
297.9
pmol/l
0.14
23
137
117
961
1.23
1.37
1.8
1.6
—
—
—
0
0
56
419
1.35
1.33
1.5
1.6
—
234.3
—
0
21
98
792
1.25
1.33
1.6
1.7
—
—
—
0
0
1545
15272
1.33
1.32
21.6
20.2
6.7
6.6
e9/l
0.25
1502
14833
753
7112
1.11
1.32
4.1
4.0
0.0
0.0
estimate
1.08
150
1284
446
4096
1.12
1.29
3.9
3.8
11.0
7.5
mg/mmol
0.61
244
2340
74
580
1.29
1.29
1.8
1.9
40.2
39.9
u/l
0.05
59
512
334
3014
1.14
1.29
1.6
1.7
30741185.5
25454994.8
pmol/l
0.06
270
2475
33
471
0.69
1.28
1.8
2.3
0.6
0.8
g/l
0.08
28
409
16
92
1.75
1.25
1.0
1.1
—
—
—
0
0
737
6972
1.11
1.23
4.0
4.0
0.0
0.0
estimate
0.00
147
1278
34
239
1.43
1.18
1.2
1.1
4.0
0.9
u/ml
0.71
14
94
41
553
0.73
1.16
2.0
2.3
7.8
7.6
g/l
0.20
27
417
41
553
0.73
1.16
2.0
2.3
—
—
—
0
0
53
405
1.32
1.13
1.4
1.5
—
—
—
0
0
368
3369
1.12
1.12
1.3
1.3
0.5
1.6
u/ml
4.75
96
882
172
1499
1.17
1.10
3.4
3.8
6.4
13.2
ug/l
1.24
132
1195
17
104
1.64
1.09
1.0
1.0
—
—
—
0
0
110
924
1.20
1.08
1.3
1.2
460.7
138.2
u/ml
0.45
102
847
87
715
1.23
1.06
1.5
1.4
—
—
—
0
0
7
33
2.13
1.05
1.0
1.0
—
—
—
0
0
7
33
2.13
1.05
1.4
1.2
—
—
—
0
0
741
7051
1.09
1.05
5.4
5.4
0.0
0.0
estimate
0.50
144
1285
898
8624
1.09
1.03
3.0
3.0
—
—
—
0
0
25
171
1.47
1.02
1.8
1.8
91.9
89.8
%
1.40
25
171
142
1227
1.17
1.02
3.2
3.2
95.6
78.2
ng/l
1.11
118
1033
10
53
1.89
1.01
2.0
2.4
—
—
—
0
0
10
53
1.89
1.01
1.4
1.4
—
—
—
0
0
146
1266
1.17
1.01
1.8
1.6
1.4
1.4
%
1.07
125
1117
55
431
1.29
1.01
1.3
1.2
—
—
—
0
0
12
68
1.77
1.00
1.3
1.3
—
—
—
0
0
12
68
1.77
1.00
1.3
1.3
—
—
—
0
0
12
68
1.77
1.00
1.3
1.3
—
—
—
0
0
12
68
1.77
1.00
1.3
1.3
—
—
—
0
0
42
317
1.33
1.00
1.7
1.7
8025.6
12281.2
e6/l
0.43
28
228
20
131
1.53
1.00
1.2
1.1
—
—
—
0
0
50
388
1.30
0.99
1.3
1.2
—
—
—
0
0
127
1471
0.85
0.98
1.9
1.6
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
1.4
1.6
umol/24h
—
5
23
37
275
1.35
0.97
2.1
2.1
129.5
128.7
g/l
0.07
25
193
11
62
1.78
0.94
1.0
1.4
—
—
—
0
0
30
217
1.39
0.93
1.1
1.1
—
—
—
0
0
36
270
1.34
0.91
1.8
1.7
—
—
—
0
0
34
253
1.35
0.90
2.6
2.3
16.6
16.2
%
0.32
15
115
94
1107
0.84
0.90
1.7
1.7
—
—
—
0
0
40
517
0.77
0.89
2.0
2.4
3.0
3.2
g/l
0.22
24
406
473
4448
1.09
0.85
2.7
2.9
28.0
32.7
u/l
1.44
444
4219
10
57
1.76
0.83
2.2
2.8
632.7
1131.2
u/ml
—
10
57
22
154
1.43
0.83
2.0
1.7
279.7
1728.4
u/ml
0.40
22
148
561
5318
1.08
0.83
4.3
4.2
—
—
—
0
0
24
171
1.41
0.83
1.4
1.3
—
—
—
0
0
167
1491
1.13
0.80
2.0
2.4
5.8
6.6
umol/l
0.26
148
1269
130
1476
0.87
0.80
1.9
1.7
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
184
2038
0.89
0.78
2.7
2.7
5.4
4.2
e6/l
0.55
104
1012
31
234
1.33
0.78
1.5
1.2
0.6
0.7
nmol/l
0.21
31
224
58
476
1.23
0.77
1.4
1.9
—
—
—
0
0
9
53
1.70
0.75
1.4
1.4
—
—
—
0
0
9
53
1.70
0.75
1.4
1.4
—
—
—
0
0
39
307
1.28
0.74
1.6
1.5
—
—
—
0
0
14
92
1.53
0.72
1.2
1.0
—
—
—
0
0
1229
12521
0.92
0.71
14.5
14.6
38.9
38.7
%
0.30
845
8893
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
9
144
0.62
0.69
1.2
1.2
—
—
—
0
0
9
146
0.61
0.69
1.9
1.4
—
—
—
0
0
224
2056
1.10
0.69
2.5
2.3
12.7
12.9
umol/l
0.19
204
1888
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
846
8197
1.07
0.66
8.2
8.8
4.1
4.0
e9/l
0.48
747
7146
19
259
0.73
0.65
1.2
1.9
1.0
0.8
nmol/l
0.35
13
204
26
199
1.31
0.62
1.3
1.8
—
—
—
0
0
6
105
0.57
0.61
1.7
1.6
1.2
1.0
g/l
—
6
105
49
407
1.21
0.61
1.7
1.6
0.6
0.1
iu/ml
—
9
75
20
267
0.75
0.61
2.9
2.4
3.7
84.2
ug/min
—
7
171
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
149
1350
1.11
0.60
2.9
2.6
1.9
1.9
%
0.12
120
1184
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
99
1117
0.88
0.60
2.4
2.5
59.6
66.0
ml/min/173m2
1.13
37
457
10
64
1.57
0.58
1.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
62
530
1.18
0.58
1.7
1.8
1.6
1.6
g/l
0.10
52
459
14
196
0.71
0.57
1.1
1.3
99.0
117.2
u/ml
—
6
38
43
356
1.21
0.56
2.4
2.6
—
—
—
0
0
24
185
1.30
0.56
1.4
1.4
7.5
7.4
mmol/l
0.05
17
135
8
55
1.46
0.56
1.0
1.1
0.3
0.3
g/l
—
8
46
21
274
0.76
0.56
1.7
1.3
—
—
—
0
0
21
274
0.76
0.56
1.7
1.3
—
—
—
0
0
11
160
0.69
0.55
1.0
1.1
—
—
—
0
0
10
65
1.54
0.55
2.3
1.3
—
—
—
0
0
116
1043
1.12
0.55
2.4
2.3
4.8
5.5
ug/l
0.33
91
897
16
116
1.38
0.54
1.2
1.2
—
—
—
0
0
16
116
1.38
0.54
1.2
1.2
—
—
—
0
0
6
38
1.58
0.54
1.3
1.2
572.2
265.9
pmol/l
—
6
30
16
117
1.37
0.52
1.2
1.2
—
—
—
0
0
16
117
1.37
0.52
1.2
1.2
—
—
—
0
0
16
117
1.37
0.52
1.2
1.2
—
—
—
0
0
16
117
1.37
0.52
1.6
2.3
2.1
2.3
u/field
—
10
50
321
3035
1.07
0.52
4.7
4.5
1.0
1.0
kg/l
0.12
50
449
207
2224
0.92
0.52
2.7
2.5
1.3
1.5
e6/l
0.34
128
1192
343
3251
1.07
0.52
1.5
1.5
23.0
22.1
nmol/l
0.50
264
2735
541
5203
1.06
0.51
2.9
3.3
2.4
2.4
mmol/l
0.33
441
4541
46
388
1.19
0.51
1.0
1.1
1.4
6.1
u/ml
—
5
48
42
352
1.20
0.50
1.9
2.3
3.6
3.6
g/l
0.09
37
337
9
65
1.39
0.50
1.4
1.5
—
—
—
0
0
231
2161
1.08
0.50
2.9
3.0
0.8
0.8
mmol/l
0.23
205
1997
270
2545
1.07
0.48
1.6
1.5
—
—
—
0
0
46
538
0.85
0.48
1.6
1.7
3.5
3.7
mg/l
0.03
41
374
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
89
797
1.12
0.47
1.0
1.0
—
—
—
0
0
29
237
1.23
0.45
2.8
2.6
8.7
8.1
kpa
0.98
29
216
7
50
1.40
0.45
1.1
1.1
114.6
192.4
iu/ml
—
7
50
35
416
0.84
0.44
1.4
1.3
162.0
229.9
miu/ml
0.80
21
202
152
1407
1.09
0.44
3.0
3.2
—
—
—
0
0
222
2088
1.07
0.43
2.0
1.8
—
—
—
0
0
27
221
1.23
0.42
1.3
1.3
—
—
—
0
0
16
122
1.31
0.42
2.2
2.5
—
—
—
0
0
242
2559
0.94
0.42
3.6
3.5
381.4
247.3
ng/l
0.37
172
1900
184
1722
1.08
0.41
2.3
2.4
21.5
21.8
%
0.14
148
1464
11
149
0.74
0.40
2.1
2.1
32.9
31.9
pg
0.49
11
149
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
7
105
0.67
0.39
2.0
1.5
—
—
—
0
0
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
27
323
0.83
0.38
1.1
1.3
3.7
3.8
mmol/l
0.35
27
304
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
12
89
1.35
0.38
1.3
1.1
—
—
—
0
0
20
161
1.25
0.37
1.4
1.3
—
—
—
0
0
42
365
1.15
0.36
2.0
2.1
15.8
11.9
mg/l
0.32
36
336
23
189
1.22
0.36
1.4
1.3
—
—
—
0
0
266
2788
0.94
0.36
2.8
2.8
2.5
2.5
mmol/l
0.27
232
2460
21
171
1.23
0.35
3.8
4.5
392.0
80.6
u/ml
—
8
49
33
384
0.86
0.35
3.8
3.4
2.4
1.9
ratio
—
5
30
83
757
1.10
0.35
1.7
1.7
—
—
—
0
0
363
3494
1.05
0.34
2.4
2.2
3.0
3.0
mg/l
0.04
306
2969
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
44
1.36
0.34
1.2
1.1
109.2
119.9
%
—
6
39
197
1864
1.06
0.34
2.4
2.3
2.4
2.4
g/l
0.08
178
1716
292
2796
1.05
0.34
2.5
2.5
5.9
7.9
e6/l
2.09
252
2437
15
118
1.27
0.33
1.5
1.4
4443.5
132189.8
e6/l
—
8
82
6
87
0.69
0.33
1.2
1.2
—
—
—
0
0
24
285
0.84
0.32
2.4
2.5
1.4
1.5
mmol/l
0.32
24
275
29
338
0.86
0.32
2.1
1.7
—
—
—
0
0
623
6081
1.04
0.32
4.4
4.3
35.7
35.6
g/l
0.22
572
5635
12
92
1.31
0.32
1.7
1.3
—
—
—
0
0
97
1047
0.92
0.31
5.8
3.2
4.6
4.5
pmol/l
0.47
84
915
123
1313
0.93
0.30
2.0
2.2
30.9
37.8
u/l
1.31
105
1112
7
55
1.27
0.30
1.0
1.1
113.7
111.3
%
—
7
47
20
166
1.21
0.30
1.8
1.6
45.5
59.6
%
—
10
98
17
206
0.82
0.29
1.6
1.1
1.2
2.9
u/ml
—
5
61
30
260
1.16
0.29
1.2
1.2
—
—
—
0
0
40
355
1.13
0.28
1.4
1.4
—
—
—
0
0
68
623
1.10
0.28
1.5
1.5
—
—
—
0
0
160
1517
1.06
0.28
5.0
5.8
104.6
104.2
mmol/l
0.41
155
1482
46
413
1.12
0.27
1.8
1.9
—
—
—
0
0
23
196
1.18
0.27
1.1
1.1
—
—
—
0
0
11
86
1.28
0.26
1.0
1.1
1.0
1.2
u/l
—
6
47
175
1669
1.05
0.25
5.1
4.5
1.1
1.0
mmol/l
0.56
158
1526
22
255
0.86
0.24
1.5
1.7
—
—
—
0
0
12
96
1.25
0.24
1.3
1.3
—
—
—
0
0
53
484
1.10
0.24
5.5
4.6
1.6
1.5
%
0.24
53
456
38
341
1.12
0.23
1.3
1.2
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
20
232
0.86
0.23
1.6
1.3
—
—
—
0
0
12
97
1.24
0.23
1.9
1.8
—
—
—
0
0
32
358
0.89
0.22
1.7
1.5
—
—
—
0
0
49
448
1.10
0.22
1.3
1.4
329.0
302.7
ug/g
0.36
28
254
25
219
1.14
0.22
1.3
1.5
—
—
—
0
0
15
178
0.84
0.22
2.1
1.4
—
—
—
0
0
34
305
1.12
0.22
2.9
4.0
31.5
24.0
mg/l
0.28
17
183
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
57
616
0.92
0.21
5.8
7.7
25.4
24.4
mmol/l
1.06
49
573
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
355
1.10
0.20
1.9
3.4
0.3
0.4
u/ml
0.41
20
206
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
143
1369
1.05
0.20
5.7
6.1
2.1
1.3
mmol/l
1.64
113
1079
12
99
1.21
0.19
1.3
1.3
—
—
—
0
0
116
1217
0.95
0.19
2.9
3.5
1.2
1.2
mmol/l
0.30
102
1051
32
289
1.11
0.19
3.1
3.4
0.9
0.8
nmol/l
0.41
26
225
40
436
0.92
0.18
2.5
1.9
6.7
4.6
iu/l
0.43
13
147
6
53
1.13
0.18
1.2
1.2
—
—
—
0
0
24
213
1.13
0.18
1.4
1.5
—
—
—
0
0
7
58
1.21
0.18
1.1
1.3
—
—
—
0
0
358
3662
0.97
0.18
3.0
3.0
0.3
0.4
e6/l
2.09
267
2715
115
1099
1.05
0.17
4.3
3.0
5.9
5.8
kpa
0.13
110
1069
52
558
0.93
0.17
4.6
3.2
24.6
24.3
mmol/l
0.20
46
496
15
129
1.16
0.17
1.1
1.1
—
55.0
—
0
15
5
67
0.75
0.17
1.2
1.5
—
68.8
%
—
0
9
120
1150
1.05
0.17
1.2
1.2
179.3
153.3
iu/ml
0.32
44
451
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
24
266
0.90
0.15
2.4
2.6
7.8
7.4
mmol/l
0.19
24
258
8
73
1.10
0.15
2.0
1.8
25.4
7.1
nmol/l
—
8
57
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
82
1.10
0.15
1.0
1.1
—
—
—
0
0
7
88
0.79
0.14
1.1
1.8
—
—
—
0
0
15
132
1.14
0.13
1.0
1.1
—
—
—
0
0
142
1376
1.04
0.13
5.7
6.1
5.2
5.1
kpa
0.53
135
1321
142
1376
1.04
0.13
5.8
6.1
12.5
12.7
kpa
0.10
134
1317
9
108
0.83
0.13
1.8
1.8
—
—
—
0
0
102
983
1.04
0.12
7.2
6.5
8.8
8.9
mmol/l
0.04
93
935
112
1083
1.04
0.12
4.4
3.0
2.3
2.1
mmol/l
0.17
94
892
31
333
0.93
0.11
1.5
1.4
—
—
—
0
0
31
332
0.93
0.11
1.5
1.4
—
—
—
0
0
21
192
1.09
0.10
1.0
1.1
3.6
2.1
u/ml
—
8
83
13
146
0.89
0.10
1.5
1.1
—
—
—
0
0
31
331
0.94
0.10
1.5
1.4
—
—
—
0
0
31
331
0.94
0.10
1.5
1.4
—
—
—
0
0
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
133
1362
0.97
0.09
3.5
4.2
235.6
254.2
u/l
1.01
120
1282
191
1876
1.02
0.08
1.7
2.0
28.7
29.3
s
0.94
183
1819
14
127
1.10
0.08
2.7
3.5
—
—
—
0
0
7
68
1.03
0.07
1.4
1.4
5.4
4.6
umol/l
—
7
63
6
75
0.80
0.07
1.5
1.3
—
—
—
0
0
6
75
0.80
0.07
15.2
12.8
0.7
0.6
mmol/l
—
6
70
6
75
0.80
0.07
1.5
1.3
—
—
—
0
0
27
286
0.94
0.07
2.7
3.6
59.6
57.5
%
0.50
27
286
7
84
0.83
0.07
1.4
1.3
—
—
—
0
0
7
85
0.82
0.07
5.0
1.7
—
—
—
0
0
28
295
0.95
0.06
1.5
1.5
—
—
—
0
0
108
1057
1.02
0.06
2.8
2.9
275.3
182.2
ng/l
0.52
102
958
34
355
0.96
0.06
1.1
1.3
459.2
503.8
mg/l
0.36
34
338
22
208
1.06
0.05
1.1
1.2
—
—
—
0
0
15
161
0.93
0.05
1.2
1.2
50.9
57.1
u/l
—
10
111
392
3891
1.01
0.05
1.7
1.6
1.3
1.4
mmol/l
0.38
339
3284
37
357
1.04
0.04
1.4
1.6
—
—
—
0
0
110
1118
0.98
0.04
2.8
2.6
66.2
66.8
g/l
0.33
98
1008
55
536
1.03
0.04
3.4
3.3
49.6
47.8
%
0.19
55
529
24
229
1.05
0.04
1.8
1.4
—
—
—
0
0
15
160
0.94
0.04
1.0
1.1
—
—
—
0
0
49
477
1.03
0.04
1.6
1.8
—
—
—
0
0
11
101
1.09
0.04
1.4
1.2
—
—
—
0
0
14
131
1.07
0.03
1.1
1.2
—
—
—
0
0
32
310
1.03
0.03
1.7
1.4
—
—
—
0
0
73
741
0.98
0.02
1.4
1.5
—
—
—
0
0
47
461
1.02
0.02
1.2
1.1
—
—
—
0
0
92
911
1.01
0.01
3.2
2.6
4.4
4.5
kpa
0.40
87
882
71
718
0.99
0.01
1.4
1.3
28.5
32.1
iu/l
0.41
65
617
46
467
0.98
0.01
1.2
1.1
—
—
—
0
0
47
477
0.98
0.01
3.3
3.1
160.5
587.7
u/ml
0.76
40
412
10
94
1.06
0.01
1.1
1.4
—
—
—
0
0
17
176
0.97
0.00
1.2
2.1
—
795.0
—
0
9
21
206
1.02
0.00
1.4
1.2
3.3
4.3
u/ml
0.31
11
78
30
304
0.99
0.00
1.7
1.4
—
—
—
0
0
19
192
0.99
0.00
1.1
1.2
317.2
254.8
u/ml
—
10
118
13
129
1.01
0.00
1.1
1.8
—
—
—
0
0
14
139
1.01
0.00
1.1
1.1
107.0
95.5
%
0.66
14
132
17
169
1.01
0.00
1.1
1.1
—
—
—
0
0
57
567
1.01
0.00
2.9
2.2
1.2
1.1
%
0.28
57
562
33
325
1.02
0.00
1.2
1.2
—
10.8
—
0
5
78
785
0.99
0.00
1.5
1.4
—
—
—
0
0
12
115
1.04
0.00
1.8
1.2
1.5
0.8
u/ml
—
5
42
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
6
64
0.94
0.00
1.2
2.0
—
—
—
0
0
5
53
0.94
0.00
1.0
1.4
—
—
—
0
0
8
79
1.01
0.00
1.3
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
4.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
6
60
1.00
0.00
1.3
1.6
14.7
14.2
pmol/l
—
6
48
5
58
0.86
0.00
1.0
1.1
1762.0
1766.6
miu/ml
—
5
58
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_FEMALE_GEN_OTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_FEMALE_GEN_OTH | 1.037 [0.92, 1.17] | 0.546 |
| Birth year | 0.991 [0.98, 1.0] | 0.056 |
During the follow-up period (1.1.1998 — 31.12.2019), 555 out of 5027 females with CD2_BENIGN_FEMALE_GEN_OTH died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_FEMALE_GEN_OTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.103% | No data |
| 5 | 0.612% | No data |
| 10 | 1.446% | No data |
| 15 | 2.636% | No data |
| 20 | 4.381% | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_FEMALE_GEN_OTH – Benign neoplasm of other and unspecified female genital organs
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data